首页> 外文期刊>Journal of applied microbiology >Bacillus subtilis WB800N alleviates diabetic wounds in mice by regulating gut microbiota homeostasis and TLR2
【24h】

Bacillus subtilis WB800N alleviates diabetic wounds in mice by regulating gut microbiota homeostasis and TLR2

机译:枯草芽孢杆菌WB800N通过调节肠道菌群稳态和TLR2来减轻小鼠的糖尿病伤口

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Objective This study aims to investigate the effect of Bacillus subtilis WB800N on diabetic wounds. Methods Haematoxylin eosin (HE) staining was used to observe the healing of skin wounds. Collagen deposition was assessed by Masson staining. Western blotting and qRT‐PCR were used to detect vascular endothelial‐related factors (VWF), CD31, TLR2, NLRP3, ASC and Caspase‐1 expression. 16S rDNA sequencing detected microbiota distribution. The concentrations of IL‐1β and IL‐37 were measured by ELISA. Apoptosis was measured by the TUNEL assay. Results Compared with the control group, wound healing was delayed in diabetic mice. The wound area in the Bacillus subtilis group decreased more significantly than the diabetic wound group. HE staining showed that Bacillus subtilis WB800N promoted wound healing and increased re‐epithelialization. Masson staining showed that Bacillus subtilis WB800N increased collagen deposition in mice with diabetic wounds. Bacillus subtilis WB800N upregulated VWF and CD31 protein expression in diabetic wounds mice. The 16S rDNA results showed that Bacillus subtilis WB800N reduced the diversity of the gut microbiota of diabetic wounds mice and regulated the microbial composition. At the genus level, Bacillus subtilis WB800N reduced the relative abundance of Muribaculaceae and CG − 005 in diabetic wounds mice, whilst increasing the relative abundance of Lactobacillus. Bacillus subtilis WB800N increased the expression of TLR2, NLRP3, ASC and Caspase‐1. Bacillus subtilis WB800N increased the concentrations of IL‐1β and IL‐37 in serum. Bacillus subtilis WB800N upregulated cell apoptosis. The TLR2 antagonist Sparstolonin B (SsnB) reduced the expression of TLR2, NLRP3, ASC, Caspase‐1, IL‐1β and IL‐37 and the apoptosis in diabetic wounds mice, whilst the combined intervention of Bacillus subtilis and SsnB reversed the effect of SsnB treatment alone. Conclusion Bacillus subtilis WB800N alleviated diabetic wound healing by regulating gut microbiota homeostasis and TLR2. Significance and impact of research Our findings might provide potential therapeutic targets for diabetic wounds.
机译:摘要 目的 探讨枯草芽孢杆菌WB800N对糖尿病创面的影响。方法 苏木精和伊红(H&E)染色观察皮肤创面愈合情况。通过Masson染色评估胶原蛋白沉积。Western blotting和qRT-PCR检测血管内皮相关因子(VWF)、CD31、TLR2、NLRP3、ASC和Caspase-1的表达。16S rDNA测序检测微生物群分布。ELISA法测定IL-1β和IL-37的浓度。通过TUNEL测定法测量细胞凋亡。结果 与对照组相比,糖尿病小鼠伤口愈合延迟。枯草芽孢杆菌组创面面积比糖尿病创面组减少更显著。H&E染色显示枯草芽孢杆菌WB800N促进伤口愈合并增加再上皮化。Masson染色结果显示,枯草芽孢杆菌WB800N增加了糖尿病创面小鼠的胶原沉积。枯草芽孢杆菌WB800N上调糖尿病伤口小鼠VWF和CD31蛋白表达。16S rDNA结果显示,枯草芽孢杆菌WB800N降低了糖尿病创面小鼠肠道菌群的多样性,调控了微生物组成。在属水平上,枯草芽孢杆菌WB800N降低了糖尿病创面小鼠Muribaculaceae和CG − 005的相对丰度,同时增加了乳酸菌的相对丰度。枯草芽孢杆菌WB800N增加TLR2、NLRP3、ASC和Caspase-1的表达。枯草芽孢杆菌WB800N增加了血清中IL-1β和IL-37的浓度。枯草芽孢杆菌WB800N上调细胞凋亡。TLR2拮抗剂Sparstolonin B(SsnB)降低了糖尿病创面小鼠TLR2、NLRP3、ASC、Caspase-1、IL-1β和IL-37的表达和凋亡,而枯草芽孢杆菌和SsnB的联合干预逆转了单独SsnB治疗的效果。结论 枯草芽孢杆菌WB800N通过调节肠道菌群稳态和TLR2缓解糖尿病创面愈合。研究的意义和影响 我们的研究结果可能为糖尿病伤口提供潜在的治疗靶点。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号